Journal of Clinical Epidemiology
Volume 49, Issue 2 , Pages 193-201 , February 1996

The role of functional status in predicting inpatient mortality with AIDS: A comparison with current predictors

  • Amy C. Justice

      Affiliations

    • Corresponding Author InformationAll correspondence should be addressed to: Dr. Amy C. Justice, MD, MS, University of Pennsylvania Medical Center, Center for Clinical Epidemiology and Biostatistics, 4200 Pine Street, Floor 2, Room 216, Philadelphia, PA 19104-4090, U.S.A..
    • Center for Health Services and Policy Research, School of Nursing, Philadelphia, Pa 19104-6096, U.S.A.
    • University of Pennsylvania, Philadelphia, Pa 19104-6096, U.S.A.
    • Division of General Internal Medicine, University of Pennsylvania Medical Center, Philadelphia, Pa, U.S.A.
    • Leonard Davis Institute of Health Care Economics, Philadelphia, Pa, U.S.A.
    • Dr. Justice was supported by the Agency for Health Care Policy and Research National Research Service Award #T32 HS00009 from the University of Pennsylvania.
    • ,
  • Linda H. Aiken

      Affiliations

    • Center for Health Services and Policy Research, School of Nursing, Philadelphia, Pa 19104-6096, U.S.A.
    • University of Pennsylvania, Philadelphia, Pa 19104-6096, U.S.A.
    • Leonard Davis Institute of Health Care Economics, Philadelphia, Pa, U.S.A.
    • Population Studies Center and Department of Sociology U.S.A.
    • ,
  • Herbert L. Smith

      Affiliations

    • University of Pennsylvania, Philadelphia, Pa 19104-6096, U.S.A.
    • Population Studies Center and Department of Sociology U.S.A.
    • ,
  • Barbara J. Turner

      Affiliations

    • Center for Health Services and Policy Research, School of Nursing, Philadelphia, Pa 19104-6096, U.S.A.
    • Leonard Davis Institute of Health Care Economics, Philadelphia, Pa, U.S.A.
    • Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pa, U.S.A.

,Revised 18 April 1995

References 

  1. Park RE, Brook RH, Kosecoff J, et al.  Explaining variations in hospital death rates: randomness, severity of illness, quality of care. JAMA. 1990;264:484–487
  2. Fahs MC, Fulop G, Strain J, et al.  The inpatient AIDS unit: an empirical investigation of access, economic, and outcome issues. Am J Public Health. 1992;82:576–578
  3. Feinstein AR. Evaluating prognosis and transitions: general strategic principles and applications to AIDS. In: National Center for Health Services Research and Health Care Technology Assessment, Public Health Services; US Department of Health and Human Services Conference Proceedings. Health Services Research Methodology: A Focus on AIDS; 1989 September;p. 189–195
  4. Donabedian A. Commentary on some studies of the quality of care. Health Care Financing Rev. 1987;75–85
  5. Chaisson RE. Living with AIDS. JAMA. 1990;263:434–435
  6. Markson L, Turner B, Fanning T. Duration of Medicaid AIDS hospitalizations: variation by season, stage, and year. Am J Public Health. 1992;82:578–580
  7. Iezzoni LI, Ash AS, Coffman GA, Moskowitz MA. Predicting in-hospital mortality: a comparison of severity measurement approaches. Med Care. 1992;30:347–359
  8. Montaner JSG, Hawley PH, Ronco JJ, et al.  Multisystem organ failure predicts mortality of ICU patients with acute respiratory failure secondary to AIDS-related PCP. Chest. 1992;102:1823–1828
  9. Knaus WA, Wagner DP, Zimmerman JE, Draper EA. Variations in mortality and length of stay in intensive care units. Ann Intern Med. 1993;118:753–761
  10. Redfield RR, Wright DC, Tremont EC. The Walter Reed staging classification for HTLV-III/LAV infection. N Engl J Med. 1986;314:131–132
  11. World Health Organization . Acquired Immunodeficiency Syndrome (AIDS) interim proposal for a WHO staging system for HIV infection and disease. Weekly Epidemiol Record. 1990;221–224
  12. Centers for Disease Control . Classification system for human Tlymphotrophic virus type III/lymphadenopathy-associated virus infection. Arch Intern Med. 1986;105:234–237
  13. Cella D, Orav J, Kornblith A, et al.  Socioeconomic status and cancer survival. J Clin Oncol. 1991;9:1500–1509
  14. Zubrod C, Schneiderman M, Frie E, et al.  Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis. 1960;11:7–33
  15. Verger E, Salamero M, Conill C. Can Karnofsky performance status be transformed to the Eastern Cooperative Oncology Group scoring scale and vice versa?. Eur J Cancer. 1995;28A:1328–1330
  16. Roila F, Lupattelli M, Sassi M, et al.  Intra and interobserver variability in cancer patients' performance status assessed according to Karnofsky and ECOG scale. Ann Oncol. 1991;2:437–439
  17. Conill C, Verger E, Salamero M. Performance status assessment in cancer patients. Cancer. 1990;65:1864–1866
  18. Falkson G, Gelman R, Leone L, et al.  Survival of premenopausal women with metastatic breast cancer: long-term follow-up of ECOG and CALGB studies. Cancer. 1990;66:1621–1629
  19. McClellan W, Anson C, Birkeli K, et al.  Functional status and quality of life: predictors of early mortality among patients entering treatment for end stage renal disease. J Clin Epidemiol. 1991;44:83–89
  20. Grabowski C, Unger J, Potish R. Factors predictive of completion of treatment and survival after palliative radiation therapy. Radiology. 1992;184:329–332
  21. Brezinski D, Stone P, Muller J, et al.  Prognostic significance of the Karnofsky Performance Status score in patients with acute myocardial infarction comparison with the left ventricular ejection fraction and the exercise treadmill test performance. Am Heart J. 1991;121:1374–1381
  22. Mor V, Laliberte L, Morris J, Wiemann M. Karnofsky Performance Status Scale: an examination of its reliability and validity in a research setting. Cancer. 1984;53:2002–2007
  23. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In:  Macleod CM editors. Evaluation of chemotherapeutic agents. New York: Columbia University Press; 1949;p. 191–205
  24. Stanton D, Wu A, Moore R, et al.  Functional status of persons with HIV infection in an ambulatory setting. J AIDS. 1994;7:1050–1056
  25. Justice AC, Feinstein AR, Wells CD. A new prognostic staging system for the acquired immunodeficiency syndrome. N Engl J Med. 1989;320:1388–1393
  26. Turner BJ, Kelly JV, Ball JK. A severity classification system for AIDS hospitalizations. Med Care. 1989;27:423–437
  27. Mills GD, Jones PD. Relationship between CD4 lymphocye count and AIDS mortality, 1986–1991. AIDS. 1993;7:1383–1386
  28. Stone VE, Seage GR, Hertz T, Epstein AM. The relation between hospital experience and mortality for patients with AIDS. JAMA. 1992;268:2655–2661
  29. Haas JS, Weissman JS, Cleary PD, et al.  Discussion of preferences for life-sustaining care by persons with AIDS: predictors of failure of patient-physician communication. Arch Intern Med. 1993;153:1241–1248
  30. Turner BJ, Ball JK. Evolution of the Severity Classification for AIDS Hospitalizations (SCAH): impact of a changing clinical spectrum of disease. 1993; (UnPub)
  31. Ball JK, Turner BJ. AIDS in US hospitals, 1986–1987: a national perspective. (AHCPR Pub. 91-0015). Hospital Studies Program Research Note 15, Agency for Health Care Policy and Research. Rockville, MD: Public Health Service; July, 1991;
  32. Bastian L, Bennett CL, Adams BR. Differences between men and women with HIV-related Pneumocystis carinii pneumonia: experience from 3,070 cases in New York City in 1987. J AIDS. 1993;6:617–623
  33. Piette J, Mor V, Fleishman J. Patterns of survival with AIDS in the United States. Health Serv Res. 1991;26:75–95
  34. Tramarin AS, Milocchi F, Tolley K, et al.  An economic evaluation of home-care assistance for AIDS patients: a pilot study in a town in northern Italy. AIDS. 1992;6:1377–1383
  35. Rosenbaum PR. The consequences of adjustment for a concomitant variable that has been affected by the treatment. J R Stat Soc. 1984;147:656–666
  36. Concato J, Horwitz RI, Feinstein AR, Elmore JG, Schiff SF. Problems of comorbidity in mortality after prostatectomy. JAMA. 1992;267:1077–1082
  37. Jollis JG, Ancukiewicz M, Delong ER, Pryor DB, Muhlbaier LH, Mark DB. Discordance of data bases designed for claims payment versus clinical systems. Implications for outcomes research. Ann Intern Med. 1993;119:844–850
  38. Green H, Wintfeld N. How accurate are hospital discharge data for evaluating effectiveness of care?. Med Care. 1993;8:719–731
  39. Stein DS, Korvik JA, Vermune SH. CD4 lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. J Infect Dis. 1992;165:352–363
  40. Taylor JM, Fahey JL, Detels R, Giorgi JV. CD4 percentage, CD4 number and CD4:CD8 ratio in HIV infection: which to choose and how to use. J AIDS. 1989;2:114–124
  41. Centers for Disease Control and Prevention . Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. JAMA. 1987;258:1114–1154
  42. Landis J, Koch G. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–174
  43. Cox DR. Regression models and life tables. J R Stat Soc. 1972;34:187–202
  44. Centor R. A visicalc program for estimating the area under a receiver operating characteristic (ROC) curve. Med Decis Making. 1985;5:139–148
  45. Altman D. Practical Statistics for Medical Research. London: Chapman and Hall; 1994;
  46. Centers for Disease Control and Prevention . US AIDS cases reported through December 1991. HIV/AIDS Surveillance Report. 1992;1–22
  47. Feinstein AR. Clinical Judgment. Malabar, FL: Krierger; 1967;
  48. Katz S, Downs T, Cash H, et al.  Progress in development of the index of ADL. Gerontologist. 1970;10:20–30
  49. Reuben D, Rubenstein L, Hirsch S, et al.  Value of functional status as a predictor of mortality: results of a prospective study. Am J Med. 1992;93:663–669
  50. Reuben D, Siu A, Kimpau S. The predictive validity of self-report and performance-based measures of function and health. J Gerontol Med Sci. 1992;47:M106–M110
  51. Seligman M, Warrell DA, Aaboulker JP, et al.  Concorde: MRC/ANRS randomized double blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet. 1994;343:871–881
  52. Cooper D, Gatell J, Kroon S, et al.  Zidovudine in persons with asymptomatic HIV-infection and CD4 cell counts greater than 400 per cubic millimeter. N Engl J Med. 1993;329:297–303
  53. De Gruttola V, Wulfshon M, Fischl MA, Tsiatis A. Modeling the relationship between survival and CD4 lymphocytes in patients with AIDS and AIDS-related complex. J AIDS. 1993;6:359–365
  54. Centers for Disease Control and Prevention . 1993 revised classification for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR. 1992;41: (NoRR-17)
  55. Hellinger FJ. Forcasting the medical care costs of the HIV epidemic: 1991–1994. Inquiry. 1991;28:213–225
  56. Vella S, Chiesi A, Volpi A, et al.  Differential survival of patients with AIDS according to the 1987 and 1993 CDC case definitions. JAMA. 1994;271:1197–1199
  57. Poses RM, Cebul RD, Collins M, et al.  The importance of disease prevalence in transporting clinical predictive rules. Ann Intern Med. 1986;6:216–223

☆ This work was supported by Grabt RO1-HS06858 from the Agency for Healt Care Policy and research and Grant R01-NR02280 from the National Institute o Nursing Research, National Institutes of Health.

PII: 0895-4356(95)00546-3

Journal of Clinical Epidemiology
Volume 49, Issue 2 , Pages 193-201 , February 1996

Article Tools